Managed healthcare and insurance company UnitedHealth Group Incorporated (UNH) recently announced that its subsidiary, UnitedHealthcare, will now offer One Care in Massachusetts for people eligible for both Medicare and MassHealth.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Following the news, shares of the company appreciated marginally to close at $450.16 on Wednesday.
The plan will be offered to people living in Bristol, Hampden, Plymouth, Suffolk, Worcester, Hampshire, Franklin, and Middlesex counties and parts of Essex County.
The UnitedHealthcare Connected for One Care plan is available for eligible adults 21 to 64 years old, who are fit for Medicare and MassHealth, including access to the plan’s care provider network, health and wellness programs, and prescription drug coverage. This comprehensive health coverage offers a customized care plan and a single point of contact for all Medicare and MassHealth services.
Management Commentary
The CEO of UnitedHealthcare Community Plan of Massachusetts, John Madondo, said, “UnitedHealthcare is excited and honored to serve the people of Massachusetts who qualify for One Care in an integrated and person-centered model of care. We look forward to fulfilling our mission of helping people live healthier lives and making the health system work better for everyone.”
See Top Smart Score Stocks on TipRanks >>
Price Target
Recently, Deutsche Bank analyst George Hill reiterated a Buy rating on the stock. The analyst, however, raised the price target from $421 to $477, which implies upside potential of 6% from current levels.
Consensus among analysts is a Strong Buy based on 13 Buys and 2 Holds. The average UnitedHealth price target of $484.80 implies upside potential of 7.7% from current levels.
Smart Score
UnitedHealth scores a 7 out of 10 from TipRanks’ Smart Score rating system, indicating that the stock is likely to perform in line with the market expectations. Shares have gained 33.2% over the past year.
Related News:
Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore
AT&T, Verizon Agree to Address 5G Air Safety Concerns — Report
Westlake to Acquire Hexion’s Global Epoxy Business for $1.2B; Shares Rise 2.7%